Pacific Biosciences Of California (PACB) Research & Development (2010 - 2026)

Pacific Biosciences Of California has reported Research & Development for 17 years, with the latest figure at $23.0 million in Q2 2026.

• On a quarterly basis, Research & Development rose 2.19% year-over-year to $23.0 million in Q2 2026; TTM through Jun 2026 was $88.4 million, a 15.5% decrease from a year earlier, with the FY2025 full-year figure at $97.3 million, down 27.88% from the prior year.
• Research & Development was $23.0 million for Q2 2026 at Pacific Biosciences Of California, up from $19.6 million in the prior quarter.
• The five-year high for Research & Development was $52.9 million in Q1 2022, with the low at $19.6 million in Q1 2026.
• Average Research & Development over 5 years is $36.4 million, with a median of $40.6 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2024: Research & Development surged 157.63% in 2022, then slumped 46.3% in 2024.
• Over 5 years, Research & Development stood at $42.6 million in 2022, then gained by 4.51% to $44.5 million in 2023, then tumbled by 38.34% to $27.5 million in 2024, then decreased by 16.7% to $22.9 million in 2025, then rose by 0.63% to $23.0 million in 2026.
• The last three Research & Development figures came in at $23.0 million (Q2 2026), $19.6 million (Q1 2026), and $22.9 million (Q4 2025), per Business Quant data.